IGC Pharma (IGC) FCF Margin (2010 - 2025)
IGC Pharma (IGC) reported FCF Margin of 1109.42% for Q3 2025, down 86064.0% year-over-year from N/an in Q3 2024, and down 157.17% quarter-over-quarter from 431.4% in Q2 2025.
IGC Pharma (IGC) FCF Margin (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of FCF Margin data on file, last reported at 1109.42% in Q3 2025.
- FCF Margin for Q3 2025 came in at 1109.42%, down 86064.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 508.68% (down 8510.0% YoY), and the FY2026 annual result was 386.12%, down 5.0% from the prior year.
- FCF Margin declined to 1109.42% in Q3 2025 per IGC's latest filing, from 431.4% in the prior quarter.
- Over five years, FCF Margin peaked at 183.39% in Q1 2024 and troughed at 4167.86% in Q3 2021.
- A 5-year average of 1092.77% and a median of 671.69% in 2022 frame the typical range for FCF Margin.
- On a YoY basis, FCF Margin climbed as much as 613201 bps in 2021 and fell as far as 197026 bps in 2021.
- A 5-year view of FCF Margin shows it stood at 1724.65% in 2021, then surged by 61 bps to 671.69% in 2022, then declined by 21 bps to 811.27% in 2023, then jumped by 36 bps to 522.96% in 2024, then slumped by 112 bps to 1109.42% in 2025.
- Business Quant data shows IGC's FCF Margin at 1109.42% in Q3 2025, 431.4% in Q2 2025, and 226.67% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,109.42% |
| Jun 30, 2025 | -431.40% |
| Mar 31, 2025 | -226.67% |
| Dec 31, 2024 | -522.96% |
| Sep 30, 2024 | -248.79% |
| Jun 30, 2024 | -658.09% |
| Mar 31, 2024 | -183.39% |
| Dec 31, 2023 | -811.27% |
| Sep 30, 2023 | -568.04% |
| Jun 30, 2023 | -268.11% |
| Mar 31, 2023 | -916.87% |
| Dec 31, 2022 | -671.69% |
| Sep 30, 2022 | -634.65% |
| Jun 30, 2022 | -1,095.75% |
| Mar 31, 2022 | -795.90% |
| Dec 31, 2021 | -1,724.65% |
| Sep 30, 2021 | -4,167.86% |
| Jun 30, 2021 | -2,524.68% |
| Mar 31, 2021 | -3,202.47% |
| Dec 31, 2020 | -1,849.07% |